Your browser doesn't support javascript.
loading
Artificial Intelligence Approach for Variant Reporting.
Zomnir, Michael G; Lipkin, Lev; Pacula, Maciej; Meneses, Enrique Dominguez; MacLeay, Allison; Duraisamy, Sekhar; Nadhamuni, Nishchal; Al Turki, Saeed H; Zheng, Zongli; Rivera, Miguel; Nardi, Valentina; Dias-Santagata, Dora; Iafrate, A John; Le, Long P; Lennerz, Jochen K.
Afiliação
  • Zomnir MG; Massachusetts General Hospital, Boston, MA.
  • Lipkin L; Massachusetts General Hospital, Boston, MA.
  • Pacula M; Massachusetts General Hospital, Boston, MA.
  • Meneses ED; Massachusetts General Hospital, Boston, MA.
  • MacLeay A; Massachusetts General Hospital, Boston, MA.
  • Duraisamy S; Massachusetts General Hospital, Boston, MA.
  • Nadhamuni N; Massachusetts General Hospital, Boston, MA.
  • Al Turki SH; Massachusetts General Hospital, Boston, MA.
  • Zheng Z; Massachusetts General Hospital, Boston, MA.
  • Rivera M; Massachusetts General Hospital, Boston, MA.
  • Nardi V; Massachusetts General Hospital, Boston, MA.
  • Dias-Santagata D; Massachusetts General Hospital, Boston, MA.
  • Iafrate AJ; Massachusetts General Hospital, Boston, MA.
  • Le LP; Massachusetts General Hospital, Boston, MA.
  • Lennerz JK; Massachusetts General Hospital, Boston, MA.
Article em En | MEDLINE | ID: mdl-30364844
ABSTRACT

Purpose:

Next-generation sequencing technologies are actively applied in clinical oncology. Bioinformatics pipeline analysis is an integral part of this process; however, humans cannot yet realize the full potential of the highly complex pipeline output. As a result, the decision to include a variant in the final report during routine clinical sign-out remains challenging.

Methods:

We used an artificial intelligence approach to capture the collective clinical sign-out experience of six board-certified molecular pathologists to build and validate a decision support tool for variant reporting. We extracted all reviewed and reported variants from our clinical database and tested several machine learning models. We used 10-fold cross-validation for our variant call prediction model, which derives a contiguous prediction score from 0 to 1 (no to yes) for clinical reporting.

Results:

For each of the 19,594 initial training variants, our pipeline generates approximately 500 features, which results in a matrix of > 9 million data points. From a comparison of naive Bayes, decision trees, random forests, and logistic regression models, we selected models that allow human interpretability of the prediction score. The logistic regression model demonstrated 1% false negativity and 2% false positivity. The final models' Youden indices were 0.87 and 0.77 for screening and confirmatory cutoffs, respectively. Retraining on a new assay and performance assessment in 16,123 independent variants validated our approach (Youden index, 0.93). We also derived individual pathologist-centric models (virtual consensus conference function), and a visual drill-down functionality allows assessment of how underlying features contributed to a particular score or decision branch for clinical implementation.

Conclusion:

Our decision support tool for variant reporting is a practically relevant artificial intelligence approach to harness the next-generation sequencing bioinformatics pipeline output when the complexity of data interpretation exceeds human capabilities.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article